[1] Lakshmi V, Sudha T, Teja VD, et al.Prevalence of central nervous system cryptococcosis in human immunodeficiency virus reactive hospitalized patients[J]. Indian J Med Microb, 2007, 25(2): 146. [2] Sloan DJ, Parris V.Cryptococcal meningitis: epidemiology and therapeutic options[ J]. Clin Epidemiol, 2014, 6(1): 169-182. [3] 刘正印, 王贵强, 朱利平, 等. 隐球菌性脑膜炎诊治专家共识[J]. 中华内科杂志,2018, 57(5):317-323. [4] 王芳,黄琛,杜艳,等. 36例新型隐球菌性脑膜炎的临床分析[J]. 中国抗生素杂志,2019,44(2):273-276. [5] Dias AI,Matsumoto FE,Melhem MS,et a1.Comparative analysis of Etest and broth miemdilution method AFST-EUCAST)for trends in antifungal drug susceptibility testing of Brazilian Cryptoeoccus neoformans isolates[J].J Med Microbiol,2006,55(12):1693-1699. [6] Pappas PG,Perfect JR,Cloud GA,et al.Cryptocoecosis in htlmanimmunodefieiency virus.negative patients in the era of effective a20le therapy[J].Clin Infect Dis,2001,33(5):690-699. [7] Husain S,Wagener MM,Singh N.Cryptococeus neoformans infection in organ transplant recipients:valtables influencing clinical characteristics and outcome[J].Emerg Infect Dis, 2001,7(3):375-381. [8] Vilchez RA,Fung J,Kusne S.Cryptoeoeeosis in organ transplant recipients:an overview[I].Am J Transplant,2002,2(7):575-580. [9] Singh N,Alexander BD,Lortholary O,et a1.Cryptococcus neoformans in organ transplant recipients:impact of ealeineurin—inhibitor agents on mortality[J].J Infect Dis,2007,195(5): 756-764. [10] 刘正印,王爱霞,李太生,等. 隐球菌性脑膜炎26例临床分析[J]. 中华内科杂志, 2002,41(8):541-543. [11] 常艳宇,胡学强.新型隐球菌性脑膜炎和(或)脑炎102例诊断与治疗经验[J].中国现代神经疾病杂志,2014,14(8):687-692. [12] Lee YC,Wang JT, Sun HY,et al.Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection[J].J Microbiol Immunol Intect,2011,44(5):338—345. [13] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心.中国艾滋病诊疗指南(2018版)[J].新发传染病电子杂志,2019,4(2):65-84. [14] Offiah CE, Naseer A .Spectrum of imaging appearances of intracranial cryptococcal infection in HIV/AIDS patients in the anti-retroviral therapy era[J]. Clin Radiol, 2016, 71(1): 9-17. [15] 许传军, 胡志亮, 魏洪霞, 等. 艾滋病患者中枢神经系统隐球菌感染的磁共振成像特征[J]. 中南大学学报(医学版), 2017, 42(10): 1184-1190. [16] 汪兰,王晓玲,朱斌,等. 颅脑隐球菌感染的磁共振影像分析[J]. 中华医院感染学杂志, 2019, 29(16):2459-2462. [17] 李超,杜超,许传军,等.艾滋病相关性颅内隐球菌感染的 MRI 表现分析[J].医学影像学杂志, 2017 ,27(10):1858-1862. [18] 杨根东, 陆普选, 詹能勇,等.2例艾滋病并发新型隐球菌性脑膜炎头颅CT表现[J]. 传染病信息, 2007, 20(6): 375-377. [19] 甘清鑫,刘晋新,张烈光,等.艾滋病合并新型隐球菌脑膜脑炎的MRI表现[J].磁共振成像,2015,6(7):491-495. [20] Corti M, Villafañe MF, Negroni R, et al.Magnetic resonance imaging findings in AIDS patients with central nervous system cryptococcosis[J]. Rev Iberoam Micol, 2008, 25(4): 211-214. [21] 李建灵, 高剑波, 张淼. 艾滋病合并脑内机遇性感染的MRI表现[J]. 磁共振成像, 2010, 1(5): 363-365. [22] 何云. 临床医生应该如何理解《中国艾滋病诊疗指南(2018版)》[J]. 新发传染病电子杂志,2019,4(2):125-128. [23] 陶然,师金川,郭永征,等. 两性霉素B去氧胆酸盐、两性霉素B脂质体和伏立康唑诱导治疗HIV相关性隐球菌脑膜炎的效果比较[J]. 新发传染病电子杂志,2019,4(1):97-102. |